Updated:
PLx Pharma Inc.
PLx Pharma Inc. was established with a focus on drug delivery technologies, operating primarily in the healthcare space. The company's strategy appears...
PLx Pharma Inc.
PLx Pharma Inc. was established with a focus on drug delivery technologies, operating primarily in the healthcare space. The company's strategy appears centered on pharmaceutical development, leveraging its proprietary drug delivery platform to address unmet medical needs. Without publicly disclosed investment activity or portfolio, its deployment approach remains unverified. No information is available regarding team size, principals, or adjacent vehicles. The firm's scale and capital base are not publicly disclosed. PLx Pharma Inc. presents as a pharmaceutical entity, distinct from asset management or investment firms. Its structural differentiator may lie in its drug delivery technology, but details are limited.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Seattle
Corporate office
Seattle, WA, United States
Additional offices
Santiago · Austin · Houston
Sector focus
Frequently asked questions
Who are the key executives at PLx Pharma Inc.?
No named executives are publicly associated with PLx Pharma Inc. in available records. The firm's leadership team is not disclosed.
What investment stages does PLx Pharma Inc. typically target?
As a pharmaceutical development firm rather than an investment entity, PLx Pharma Inc. does not target investment stages. Its focus is on drug development and commercialization, not capital allocation.
How can I contact PLx Pharma Inc.?
No direct contact information is publicly available for PLx Pharma Inc. The firm maintains offices in Seattle, Santiago, Austin, and Houston, but specific addresses or phone numbers are not listed.
Does PLx Pharma Inc. have any publicly disclosed partnerships or portfolio companies?
No partnerships or portfolio companies have been publicly disclosed by PLx Pharma Inc. The firm's operational details remain private.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: